Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra D Bohling

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Leukemia Research|August 28, 2007
Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphomaSandra D Bohling, Stephen D Jenson, David K Crockett, et al.
FEBS Letters|July 4, 2002
Gene expression profiling of cell lines derived from T-cell malignanciesG Chris Fillmore, Zhaosheng Lin, Sandra D Bohling, et al.
The American Journal of Surgical Pathology|June 27, 2003
BCL-2 is consistently expressed in hyperplastic marginal zones of the spleen, abdominal lymph nodes, and ileal lymphoid tissueBrenton A Meda, Michael Frost, James Newell, et al.
Journal of Pediatric Hematology/Oncology|April 7, 2023
CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic LeukemiaTimothy J D Ohlsen, Erin R Rudzinski, Sandra D Bohling, et al.
Journal of Human Immunity|May 6, 2026
X-linked SEPTIN6-related congenital neutropenia and B cell deficiencyLauren M Gunderman, Aleksandra Petrovic, Ingrid Lundgren, et al.
Hemasphere|December 10, 2025
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statementAdam Lamble, Sandra D Bohling, Kara L Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2003
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapyKojo S J Elenitoba-Johnson, Stephen D Jenson, Robert T Abbott, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Leukemia Research|August 28, 2007
Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphomaSandra D Bohling, Stephen D Jenson, David K Crockett, et al.
FEBS Letters|July 4, 2002
Gene expression profiling of cell lines derived from T-cell malignanciesG Chris Fillmore, Zhaosheng Lin, Sandra D Bohling, et al.
The American Journal of Surgical Pathology|June 27, 2003
BCL-2 is consistently expressed in hyperplastic marginal zones of the spleen, abdominal lymph nodes, and ileal lymphoid tissueBrenton A Meda, Michael Frost, James Newell, et al.
Journal of Pediatric Hematology/Oncology|April 7, 2023
CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic LeukemiaTimothy J D Ohlsen, Erin R Rudzinski, Sandra D Bohling, et al.
Journal of Human Immunity|May 6, 2026
X-linked SEPTIN6-related congenital neutropenia and B cell deficiencyLauren M Gunderman, Aleksandra Petrovic, Ingrid Lundgren, et al.
Hemasphere|December 10, 2025
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statementAdam Lamble, Sandra D Bohling, Kara L Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 21, 2003
Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapyKojo S J Elenitoba-Johnson, Stephen D Jenson, Robert T Abbott, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
Pageof 2